Published in Diabetes on October 01, 1995
Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study. Diabet Med (2013) 1.51
Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetes. J Clin Endocrinol Metab (2007) 1.28
Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care (2013) 1.22
Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program. J Clin Endocrinol Metab (2013) 1.09
Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis. Diabetes Rev (Alex) (1) 0.95
Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes. Diabetes Care (1999) 0.93
Cardiovascular risk factors among youth with and without type 2 diabetes: differences and possible mechanisms. Diabetes Care (2008) 0.89
LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes. Atherosclerosis (2006) 0.86
Lipoprotein (a): impact by ethnicity and environmental and medical conditions. J Lipid Res (2015) 0.81
Lipoprotein(a) and cardiovascular disease in diabetic patients. Clin Lipidol (2012) 0.81
Association of glycaemia with lipids in adults with type 1 diabetes: modification by dyslipidaemia medication. Diabetologia (2010) 0.80
Anti-atherogenic potential of jujube, saffron and barberry: anti-diabetic and antioxidant actions. EXCLI J (2015) 0.78
Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia. Am J Obstet Gynecol (2015) 0.76
Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes. J Lipid Res (2015) 0.76
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes (1986) 5.32
Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol (1995) 4.83
Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol (1987) 4.27
Cardiovascular risk factors in young adults. The CARDIA baseline monograph. Control Clin Trials (1991) 3.30
A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA (1993) 3.18
Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med (1990) 3.17
Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. JAMA (1994) 3.11
Lipoprotein (a) levels in diabetes mellitus: relationship to metabolic control. Ann Intern Med (1992) 2.16
Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci U S A (1980) 2.13
Lipoprotein(a) levels in black and white children and adolescents with IDDM. Diabetes Care (1991) 1.81
Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem (1995) 1.80
Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis (1984) 1.73
Human plasma lipoprotein [a]. Structural properties. J Biol Chem (1983) 1.68
Increased serum levels of lipoprotein(a) in diabetes mellitus and their reduction with glycemic control. JAMA (1990) 1.66
Lipoprotein(a) in cirrhosis. BMJ (1992) 1.63
Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome. Ann Intern Med (1993) 1.50
Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus. Diabetologia (1993) 1.42
Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia (1987) 1.41
Lipoprotein(a) concentration in diabetes: relationship to proteinuria and diabetes control. Aust N Z J Med (1992) 1.39
Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria. BMJ (1991) 1.30
Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb (1993) 1.24
Lipoprotein(a) and atherosclerosis. Ann Intern Med (1991) 1.21
Decrease of lipoprotein(a) with improved glycemic control in IDDM subjects. Diabetes Care (1991) 1.16
Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study. Arterioscler Thromb (1993) 1.09
Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res (1993) 1.06
Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis (1984) 1.06
Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin. Clin Chem (1989) 1.05
Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol (1994) 1.02
Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis (1989) 1.01
Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. American Diabetes Association. Diabetes Care (1989) 1.01
A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitus. Diabetes Res Clin Pract (1992) 0.97
Serum lipoprotein(a) in patients with diabetes mellitus. Diabetes Care (1993) 0.92
Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia. Arterioscler Thromb (1993) 0.89
Lipoprotein (a) and microvascular disease in type 1 (insulin-dependent) diabetes. Diabet Med (1991) 0.85
Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease. Med Clin North Am (1994) 0.84
Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria. Diabetes (1991) 0.84
Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Metabolism (1992) 0.83
Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: cholesterol acyltransferase activity in diabetes mellitus. Atherosclerosis (1983) 0.83
Relationship of progressively increasing albuminuria to apoprotein(a) and blood pressure in type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetic patients. Diabetologia (1993) 0.81
Lipoprotein(a) in patients with proteinuria. Nephrol Dial Transplant (1992) 0.81
Lipoprotein(a) in diabetic patients with and without chronic renal failure. Diabetes Care (1992) 0.80
Atherogenic lipids and lipoproteins in hemodialysis patients. Am J Kidney Dis (1993) 0.79
Apolipoprotein(a) in insulin-dependent diabetic patients with and without diabetic nephropathy. Scand J Clin Lab Invest (1992) 0.79
Polymorphism of apolipoprotein E, lipoprotein(a), and other lipoproteins in children with type I diabetes. Clin Chem (1993) 0.79
Lipoprotein(a) in diabetes mellitus. Clin Chim Acta (1993) 0.79
Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients. Acta Diabetol (1993) 0.79
Normal lipoprotein(a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest (1992) 0.79
Lp(a) serum concentrations and metabolic control. Diabetes Care (1992) 0.79
Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort. Diabetes Care (1993) 0.78
Lipoprotein (a) levels in end-stage renal failure and renal transplantation. Nephron (1993) 0.78
Lipoprotein(a) predicts the risk of thrombogenic complications in nephrotic syndrome. Nephron (1992) 0.78
Lipoprotein(a) in nephrotic syndrome. Kidney Int (1993) 0.78
Association of lipoprotein(a) with puberty in IDDM. Diabetes Care (1993) 0.78
Lipoprotein(a) and treatment of chronic renal disease. J Intern Med (1993) 0.77
Lipoprotein(a) levels in Japanese children with IDDM. Diabetes Care (1993) 0.77
Serum lipoprotein (a) levels in maintenance hemodialysis patients. Nephron (1993) 0.77
Lipoprotein(a) in patients treated by continuous ambulatory peritoneal dialysis. Am J Kidney Dis (1993) 0.76
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia (2003) 5.91
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med (1992) 4.90
Structural-functional relationships in diabetic nephropathy. J Clin Invest (1984) 4.78
The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med (1993) 4.34
Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med (1998) 4.30
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol (1993) 3.17
Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation (1999) 3.16
Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr (2001) 2.98
Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol (1998) 2.74
Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol (1996) 2.60
Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab (1976) 2.39
A weighted and directed interareal connectivity matrix for macaque cerebral cortex. Cereb Cortex (2012) 2.35
Weight consistency specifies regularities of macaque cortical networks. Cereb Cortex (2010) 2.30
Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med (1989) 2.21
Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut (1985) 2.20
Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort. Diabetologia (2010) 2.19
Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis (1989) 2.14
Aspirin in the aetiology of Crohn's disease and ulcerative colitis: a European prospective cohort study. Aliment Pharmacol Ther (2011) 2.12
Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. J Am Soc Nephrol (1993) 1.99
Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected]. Kidney Int (1993) 1.90
Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med (1987) 1.87
Maturation and connectivity of the visual cortex in monkey is altered by prenatal removal of retinal input. Nature (1989) 1.77
Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study. Circulation (2000) 1.76
Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol (2010) 1.76
Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes (1975) 1.74
Laminar distribution of neurons in extrastriate areas projecting to visual areas V1 and V4 correlates with the hierarchical rank and indicates the operation of a distance rule. J Neurosci (2000) 1.74
Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). JAMA (1995) 1.74
Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis (1984) 1.73
Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet (1993) 1.70
ON THE RELATION OF THE VOLUME OF THE CORONARY CIRCULATION TO THE FREQUENCY AND FORCE OF THE VENTRICULAR CONTRACTION IN THE ISOLATED HEART OF THE CAT. J Exp Med (1897) 1.68
Factorial invariance across gender for the primary symptom dimensions of the SCL-90. Br J Soc Clin Psychol (1977) 1.67
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects. AIDS (2000) 1.60
Rationale of the diet-heart statement of the American Heart Association. Report of the Nutrition Committee. Circulation (1993) 1.58
Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J Biol Chem (1994) 1.53
Seven-year trends in plasma low-density-lipoprotein-cholesterol in young adults: the CARDIA Study. Ann Epidemiol (1996) 1.53
Transcriptional activation of the lipoprotein lipase and apolipoprotein E genes accompanies differentiation in some human macrophage-like cell lines. Biochemistry (1988) 1.52
Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a). Clin Chem (2000) 1.52
The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes (1978) 1.52
Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study. Diabet Med (2013) 1.51
A double-labeling investigation of the afferent connectivity to cortical areas V1 and V2 of the macaque monkey. J Neurosci (1985) 1.47
The kidney in diabetes. Am J Med (1981) 1.47
Induction of depressive affect after prolonged exposure to a mildly depressed individual. J Pers Soc Psychol (1985) 1.46
Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res (1983) 1.46
Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. J Nutr (2001) 1.45
Development of lipoprotein lipase in cultured 3T3-L1 cells. Biochem Biophys Res Commun (1977) 1.43
Stability of haemoglobin A1c (HbA1c) measurements from frozen whole blood samples stored for over a decade. Diabet Med (2005) 1.42
Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity. J Clin Invest (1975) 1.42
Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans. J Lipid Res (1996) 1.42
Subcellular localization of proinsulin to insulin conversion in isolated rat islets. Endocrinology (1970) 1.42
A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency. Proc Natl Acad Sci U S A (1989) 1.41
Body fat distribution and dyslipidemia. Am J Med (1995) 1.40
Human adipose tissue lipoprotein lipase: changes with feeding and relation to postheparin plasma enzyme. Am J Physiol (1985) 1.38
Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest (1973) 1.38
Sweet tooth reconsidered: taste responsiveness in human obesity. Physiol Behav (1985) 1.37
Single vertical spin density gradient ultracentrifugation. Methods Enzymol (1986) 1.36
The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med (1989) 1.35
Estimation of glomerular volume: a comparison of four methods. Kidney Int (1992) 1.35
Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes (1994) 1.33
Contrast sensitivity and other vision tests in the optic neuritis treatment trial. Am J Ophthalmol (1996) 1.31
Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: direct evidence that lipoprotein lipase bridging occurs in vivo. Proc Natl Acad Sci U S A (1998) 1.31
Comparison of selective media for the isolation of salmonellae. J Clin Pathol (1965) 1.29
The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Ophthalmology (1994) 1.29
Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial. JAMA (1993) 1.28
The natural history of cholelithiasis: the National Cooperative Gallstone Study. Ann Intern Med (1984) 1.28
Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes (1978) 1.28
Human lipoprotein lipase: relationship of activity, heparin affinity, and conformation as studied with monoclonal antibodies. J Lipid Res (1992) 1.27
Effect of a fat free, high carbohydrate diet on diabetic subjects with fasting hyperglycemia. Diabetes (1974) 1.27
Association between asthma and serum adiponectin concentration in women. Thorax (2008) 1.27
Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc Natl Acad Sci U S A (1996) 1.27
The visceral adiposity syndrome in Japanese-American men. Obes Res (1994) 1.26
Lipoprotein lipase secretion by human monocyte-derived macrophages. J Clin Invest (1982) 1.26
Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia. Eur J Clin Invest (1980) 1.25
Velocity sensitivity and direction selectivity of neurons in areas V1 and V2 of the monkey: influence of eccentricity. J Neurophysiol (1986) 1.25
Quantification of cholesterol in all lipoprotein classes by the VAP-II method. J Lipid Res (1994) 1.25
Improved glucose tolerance with high carbohydrate feeding in mild diabetes. N Engl J Med (1971) 1.25
Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb (1993) 1.24
Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int (1993) 1.23
Increase of adipose tissue lipoprotein lipase activity with weight loss. J Clin Invest (1981) 1.23
Cell-cycle kinetics of neocortical precursors are influenced by embryonic thalamic axons. J Neurosci (2001) 1.23
Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. J Lab Clin Med (1980) 1.23
The timetable of laminar neurogenesis contributes to the specification of cortical areas in mouse isocortex. J Comp Neurol (1997) 1.22
Cardiovascular complications in renal failure. J Am Soc Nephrol (1991) 1.21